Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

BACKGROUND: The first meningococcal serogroup C (MenC) conjugate vaccine was licensed in 1999 and introduced in the United Kingdom. Countries that have implemented the MenC vaccine since then in their national immunisation programmes use different schedules. Nevertheless, all involved countries seem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaaijk, Patricia, van der Ende, Arie, Berbers, Guy, van den Dobbelsteen, Germie PJM, Rots, Nynke Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293716/
https://www.ncbi.nlm.nih.gov/pubmed/22316426
http://dx.doi.org/10.1186/1471-2334-12-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293716/
https://www.ncbi.nlm.nih.gov/pubmed/22316426
http://dx.doi.org/10.1186/1471-2334-12-35

Ejemplares similares